Tubingen, Germany · Founded 2015 · Privately Held (backing)
Developer of novel therapies designed to treat acute and chronic liver diseases. HepaRegenix is based in Tubingen, Germany and was founded in 2015. Its last reported valuation was $43.2 million in Jan 2020. It has raised $45.3 million.
Last reported valuation
$43.2M
Oct 2026
Priced at
—
Total raised
$45.3M
Last round
—
Cap table — not yet on record
HepaRegenix's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of HepaRegenix with a free account
·Watch HepaRegenix: the Monday email on marks, rounds and moves
